HOME › DRUGS › TELBIVUDINE
ACTIVE SUBSTANCE / INN

TELBIVUDINE

Brand name(s): Sebivo, TYZEKA
FDA LISTED
EMA LISTED
WITHDRAWN
DISCONTINUED
NDA022011
Hepatitis B, Chronic
ACTIVE SUBSTANCE
Telbivudine
REGULATORS
FDA · EMA
SPONSORS / MAH
NOVARTIS, Novartis Europharm Limited
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TYZEKANDA022011NOVARTISDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SebivoNovartis Europharm LimitedWithdrawn24/04/2007Hepatitis B, Chronic

FULL INTELLIGENCE ON TELBIVUDINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →